| scholarly article | Q13442814 |
| P2093 | author name string | Sang-Youel Park | |
| Uddin Md Nazim | |||
| Honghua Yin | |||
| P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy | Q21996341 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 | ||
| Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 | ||
| Inhibition of macroautophagy triggers apoptosis | Q24338482 | ||
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| Apoptosis by death factor | Q28304002 | ||
| Observation on serum anti-double stranded DNA antibodies of tripterine in systemic lupus erythematosus of (NZBxW)F1 mice | Q43050575 | ||
| Caspase-3 activity and carbonyl cyanide m-chlorophenylhydrazone-induced apoptosis in HL-60. | Q43626504 | ||
| The protonophore CCCP induces mitochondrial permeability transition without cytochrome c release in human osteosarcoma cells | Q43713494 | ||
| Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. | Q43903493 | ||
| Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol | Q44603146 | ||
| Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice | Q46445649 | ||
| Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. | Q46644015 | ||
| Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells. | Q53285162 | ||
| Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells | Q28544861 | ||
| Autophagy: renovation of cells and tissues | Q29547206 | ||
| Autophagy: process and function | Q29547296 | ||
| Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 | ||
| Mitochondrial control of cell death | Q29617739 | ||
| Preclinical studies of celastrol and acetyl isogambogic acid in melanoma. | Q33305774 | ||
| Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer | Q33618353 | ||
| PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux | Q33688828 | ||
| Safety and antitumor activity of recombinant soluble Apo2 ligand | Q33855449 | ||
| New insights into apoptosis signaling by Apo2L/TRAIL. | Q34022690 | ||
| TRAIL/Apo-2L: mechanisms and clinical applications in cancer | Q34482821 | ||
| Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice | Q34519965 | ||
| Mitochondria: releasing power for life and unleashing the machineries of death | Q35071387 | ||
| Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy. | Q35134424 | ||
| TRAIL and apoptosis induction by TNF-family death receptors. | Q35591708 | ||
| Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications | Q35781710 | ||
| On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics | Q35853714 | ||
| Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. | Q36080043 | ||
| Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages | Q36205312 | ||
| Drug combination therapy increases successful drug repositioning | Q37004251 | ||
| The TRAIL apoptotic pathway in cancer onset, progression and therapy | Q37278043 | ||
| Autophagy: principles and significance in health and disease | Q37330775 | ||
| TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges | Q37370856 | ||
| Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review | Q38902171 | ||
| Effect of dual inhibition of apoptosis and autophagy in prostate cancer | Q39412943 | ||
| Uncouplers of oxidative phosphorylation can enhance a Fas death signal | Q39445447 | ||
| Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways | Q39501449 | ||
| Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis | Q39621306 | ||
| Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer | Q39649021 | ||
| Naringenin up‐regulates the expression of death receptor 5 and enhances TRAIL‐induced apoptosis in human lung cancer A549 cells | Q39673949 | ||
| Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy | Q40006232 | ||
| A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells | Q40024013 | ||
| Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation | Q40207449 | ||
| Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy | Q40250473 | ||
| Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells | Q40329437 | ||
| Celastrol inhibits pro-inflammatory cytokine secretion in Crohn's disease biopsies. | Q40521217 | ||
| Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 | ||
| Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. | Q41747264 | ||
| Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells | Q41914959 | ||
| Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells | Q41935560 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| reactive oxygen species | Q424361 | ||
| molecular medicine | Q3523816 | ||
| P577 | publication date | 2018-12-12 | |
| P1433 | published in | Molecular Medicine Reports | Q26842180 |
| P1476 | title | Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAIL‑induced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species |
Search more.